Microsomal enzyme induction in patients with decompensated cirrhosis
نویسندگان
چکیده
منابع مشابه
Improving Survival in Patients with Decompensated Cirrhosis
About 60% of patients with decompensated disease have oesophageal varices. One third of these patients will experience variceal bleed. Each bleeding episode compromises the decompensated state and is associated with a 20% to 30% mortality. Bleeding from ectopic varices is rare but is generally massive and life threatening. The first two articles, " Clin-icopathological features and treatment of...
متن کاملMinimal hepatic encephalopathy in patients with decompensated liver cirrhosis.
Minimal hepatic encephalopathy (mHE) is characterized by some minimal unspecific alterations of cerebral functions that can only be detected by neuropsychological or neurophysiological diagnostic tests, which dysfunctions nevertheless interfere with the patient's daily living. Early recognition of these impairments may prevent the progression or delay the development of the disease to overt hep...
متن کاملInvasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series
BACKGROUND Opportunistic invasive fungal infections are increasingly frequent in intensive care patients. Their clinical spectrum goes beyond the patients with malignancies, and for example invasive pulmonary aspergillosis has recently been described in critically ill patients without such condition. Liver failure has been suspected to be a risk factor for aspergillosis. CASE PRESENTATION We ...
متن کاملManagement of Coagulopathy in Patients with Decompensated Liver Cirrhosis
Patients with decompensated liver cirrhosis have significantly impaired synthetic function. Many proteins involved in the coagulation process are synthesized in the liver. Routinely performed tests of the coagulation are abnormal in patients with decompensated liver cirrhosis. This has led to the widespread belief that decompensated liver cirrhosis is prototype of acquired hemorrhagic coagulopa...
متن کاملPrescribing Medications in Patients with Decompensated Liver Cirrhosis
Patients with decompensated liver cirrhosis have various serious complications which require multiple drugs for therapeutic or prophylactic use. Majority of the drugs are primarily metabolized and excreted by hepatobiliary system; hence, liver cell necrosis contributes to impaired drug handling in liver failure while portosystemic shunt can alter drug action in cirrhosis. Hence, in order to dec...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gastroenterology
سال: 1980
ISSN: 0016-5085
DOI: 10.1016/0016-5085(80)90283-8